IonQ’s, Revenue

IonQ’s 755% Revenue Jump Lifts Stock, but RSI at 75.54 and 21% Short Interest Signal Risk

31.05.2026 - 18:33:22 | boerse-global.de

IonQ surged 31% in May on strong Q1 and SkyWater deal. Overbought RSI, high short interest, no CHIPS funding pose risks. Macro data this week key.

IonQ’s 755% Revenue Jump Lifts Stock, but RSI at 75.54 and 21% Short Interest Signal Risk - Foto: über boerse-global.de
IonQ’s 755% Revenue Jump Lifts Stock, but RSI at 75.54 and 21% Short Interest Signal Risk - Foto: über boerse-global.de

IonQ enters June on a high note after a 31% surge in May, but the coming weeks will test whether the quantum computing company’s fundamentals can sustain the momentum. The stock closed Friday at $72.07, within striking distance of its 52-week high of $84.64, yet a raft of technical and macro signals suggest the path ahead is anything but smooth.

The rally has concrete underpinnings. IonQ reported first-quarter 2026 GAAP revenue of $64.7 million, a 755% jump from a year earlier, while remaining performance obligations swelled to $470 million — more than quintupled. Notably, 60% of sales came from commercial clients, reducing the company’s reliance on government contracts. On the strategic front, the planned $1.8 billion acquisition of semiconductor foundry SkyWater Technology cleared a key hurdle when SkyWater shareholders approved the deal. Regulatory approvals are still pending, with IonQ targeting a closing in the second or third quarter of 2026. The merger would give IonQ direct access to U.S. fabrication capacity; test runs for its 256-qubit chip have already begun on SkyWater lines, and the long-term goal is to build systems capable of 200,000 qubits.

Yet the technical picture is flashing caution. The relative strength index hit 75.54, deep in overbought territory. The 50-day moving average sits at $43.74 and the 200-day at $47.84, with a confluence support zone between $44.50 and $46.50. The stock’s 12-month range spans $25.89 to $84.64, placing the current price near the upper end. Trading volume on Friday came in at 28.35 million shares, below the 34.13 million average, suggesting buying enthusiasm may be waning.

Adding to the tension, short interest remains elevated at roughly 21% of the float, despite a 12% decline in short positions. Institutional investors hold 41% of outstanding shares — a level that can amplify both rallies and selloffs.

Should investors sell immediately? Or is it worth buying IonQ?

The federal quantum landscape adds another layer of complexity. In May, the U.S. Commerce Department pledged over $2 billion from the CHIPS and Science Act to quantum companies. IBM received $1 billion for a dedicated quantum foundry, GlobalFoundries $375 million, and seven other firms — including D-Wave, Rigetti, and Quantinuum — up to $100 million each. IonQ was not on the list. The stock still rose in sympathy, and analysts at B. Riley point to IonQ’s $3.3 billion cash position and a DARPA contract as evidence the company is carving its own path in defense and intelligence work.

This week, no IonQ-specific events are on the calendar, shifting attention to U.S. macroeconomic data that can sway high-multiple tech names. The JOLTS job openings report arrives Monday, followed by revised productivity and unit labor costs Wednesday, and the May jobs report on Friday. A strong labor market could dent rate-cut expectations, pressuring growth stocks; weak data would likely fuel risk appetite.

The company’s next scheduled appearances come on June 9 at the Mizuho Global Technology Conference in New York and June 10 at the Rosenblatt Annual Technology Summit. Both are expected to provide updates on the SkyWater integration progress and photonic interconnect technology. The annual shareholder meeting follows on June 16. Management’s tone on those calls — particularly regarding the timeline for first 256-qubit deliveries, which Morgan Stanley expects no earlier than the first half of 2027 — will be critical.

IonQ at a turning point? This analysis reveals what investors need to know now.

Valuation remains extreme. IonQ trades at roughly 61 times expected 2027 revenue, and the adjusted EBITDA loss for 2026 is forecast between $310 million and $330 million. Jefferies, Wedbush, JPMorgan, and Morgan Stanley have all raised or reaffirmed price targets after the quarterly report, but the stock’s trajectory hinges on whether the technical overbought condition resolves through consolidation, a pullback, or an accelerated breakout past $72.17. For now, the bulls have the fundamentals on their side; the bears have the charts.

Ad

IonQ Stock: New Analysis - 31 May

Fresh IonQ information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated IonQ analysis...

So schätzen die Börsenprofis IonQ’s Aktien ein!

<b>So schätzen die Börsenprofis IonQ’s Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | US46222L1089 | IONQ’S | boerse | 69457196 |